Old Web
English
Sign In
Acemap
>
authorDetail
>
Josiah Hawks
Josiah Hawks
University of Utah
Oncology
Medicine
Internal medicine
Refractory
Prostate cancer
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combination therapy with avelumab (Ave) and cabozantinib (Cabo) in patients (pts) with newly diagnosed metastatic clear cell renal cell carcinoma (mccRCC).
2021
Journal of Clinical Oncology
Haoran Li
Umang Swami
Kenneth M. Boucher
Sumati Gupta
Josiah Hawks
Deepika Sirohi
Neeraj Agarwal
Benjamin Louis Maughan
Show All
Source
Cite
Save
Citations (0)
Randomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) versus EZ alone in metastatic castration-refractory prostate cancer (mCRPC): Long-term follow up of secondary endpoints.
2020
Journal of Clinical Oncology
Benjamin Louis Maughan
Andrew W. Hahn
Roberto H. Nussenzveig
John M. Hoffman
Kathryn A. Morton
Sumati Gupta
Julia A. Batten
Jared Thorley
Josiah Hawks
Victor Sacristan Santos
Gayatri Nachaegari
Xuechen Wang
Kenneth M. Boucher
Benjamin Haaland
Neeraj Agarwal
Show All
Source
Cite
Save
Citations (0)
Safety data from a phase II randomized trial of radium-223 dichloride (Ra-223) plus enzalutamide (Enza) vs. Enza alone in men with metastatic castration refractory prostate cancer (mCRPC).
2018
Journal of Clinical Oncology
Benjamin L. Maughan
John M. Hoffman
Kathryn A. Morton
Bhasker Rao Koppula
Julia A. Batten
Jared Thorley
Josiah Hawks
Kenneth M. Boucher
Neeraj Agarwal
Show All
Source
Cite
Save
Citations (2)
1